<!doctype html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <title>Bronchiectasis exacerbation — DGRefHelp Drafts</title>
  <link rel="stylesheet" href="../assets/site.css" />
</head>
<body>
  <div class="container">
    <div class="header">
      <div class="brand">
        <h1><a href="../index.html">DGRefHelp drafts</a> / Bronchiectasis exacerbation</h1>
        <div class="sub">Adults with known (or likely) bronchiectasis: recognise an acute exacerbation, send sputum, start appropriate oral antibiotics (guided by prior cultures), escalate early if severe/unwell or not improving, and ensure airway clearance advice.</div>
      </div>
      <div class="badges">
        <div class="badge">Mode: quick</div>
        <div class="badge">Last updated: 2026‑02‑10</div>
      </div>
    </div>

    <div class="grid">
      <div class="card">
        <div class="card-hd">
          <div class="tabs" data-tabs>
            <button class="tab" role="tab" data-tab="evidence" aria-selected="true">Evidence</button>
            <button class="tab" role="tab" data-tab="draft" aria-selected="false">DGRefHelp draft</button>
            <button class="tab" role="tab" data-tab="refs" aria-selected="false">References</button>
          </div>
          <div class="copybar">
            <button class="btn" data-copy-target="#draftText">Copy draft</button>
            <button class="btn" data-copy-target="#evidenceText">Copy evidence</button>
          </div>
        </div>

        <div class="card-bd">
          <div class="panel active" role="tabpanel" data-panel="evidence">
            <div id="evidenceText" class="section">
<h3>Evidence summary (triangulated)</h3>

              <div class="callout ok">
                <strong>Key design points</strong>
                <ul>
                  <li>NICE antimicrobial guidance (NG117) defines an acute exacerbation as a <strong>sustained worsening</strong> from the person’s baseline, and recommends <strong>sending sputum for culture/susceptibility</strong> and <strong>offering antibiotics</strong>, using <strong>prior sputum results</strong> to guide choice where possible.</li>
                  <li>NICE NG117 recommends <strong>oral antibiotics first line</strong> when the person can take oral treatment and is not severely unwell, and emphasises <strong>reassessment</strong> if rapidly worsening or not improving; refer to hospital for suspected serious illness (e.g. sepsis/cardiorespiratory failure).</li>
                  <li>BTS bronchiectasis guideline (Thorax 2019) frames exacerbations as an acute deterioration over days with worsening cough and sputum volume/viscosity and/or <strong>increased sputum purulence</strong> (± wheeze, breathlessness, haemoptysis, systemic upset). BTS supports using <strong>previous bacteriology</strong> to target antibiotics, and commonly uses <strong>14 days</strong> for exacerbation antibiotic courses (especially in more severe disease / Pseudomonas).</li>
                </ul>
            </div>
          </div>

          <div class="panel" role="tabpanel" data-panel="draft">

            <div class="callout" style="margin-bottom:12px">
              <strong>Copy/paste HTML for Right Decisions accordion sections</strong>
              <div class="small">Per your preference, these snippets contain section content only (no internal headings). Paste each into the matching accordion section.</div>
              <div style="height:10px"></div>
              <div class="copybar" style="justify-content:flex-start">
                <button class="btn" data-copy-target="#htmlBackground">Copy Background HTML</button>
                <button class="btn" data-copy-target="#htmlAssessment">Copy Assessment HTML</button>
                <button class="btn" data-copy-target="#htmlPCM">Copy Primary care mgmt HTML</button>
                <button class="btn" data-copy-target="#htmlRefer">Copy Who to refer HTML</button>
                <button class="btn" data-copy-target="#htmlNotRefer">Copy Who not to refer HTML</button>
                <button class="btn" data-copy-target="#htmlRefs">Copy References HTML</button>
              </div>

              <details style="margin-top:10px">
                <summary class="small" style="cursor:pointer">Show HTML snippets</summary>

                <h4 style="margin:12px 0 6px">Background (HTML)</h4>
                <pre id="htmlBackground">&lt;ul&gt;
                &lt;li&gt;This page is for &lt;strong&gt;adults&lt;/strong&gt; with &lt;strong&gt;known or likely bronchiectasis&lt;/strong&gt; in primary care.&lt;/li&gt;
                &lt;li&gt;&lt;strong&gt;Acute exacerbation&lt;/strong&gt; = &lt;strong&gt;sustained worsening&lt;/strong&gt; from baseline over days, typically with worsening cough and &lt;strong&gt;increased sputum volume/purulence&lt;/strong&gt; (± breathlessness, wheeze, haemoptysis, systemic upset).&lt;/li&gt;
                &lt;li&gt;Separate pathway may be needed for: pregnancy, children, severe immunocompromise, cystic fibrosis, and patients under specialist shared-care protocols.&lt;/li&gt;
              &lt;/ul&gt;</pre>

                <h4 style="margin:12px 0 6px">Assessment (primary care) (HTML)</h4>
                <pre id="htmlAssessment">&lt;ul&gt;
                &lt;li&gt;&lt;strong&gt;Severe breathlessness&lt;/strong&gt;, respiratory distress, hypoxia, exhaustion, cyanosis.&lt;/li&gt;
                &lt;li&gt;&lt;strong&gt;Sepsis&lt;/strong&gt; / systemically very unwell.&lt;/li&gt;
                &lt;li&gt;&lt;strong&gt;Large-volume haemoptysis&lt;/strong&gt; or haemoptysis with instability.&lt;/li&gt;
                &lt;li&gt;Concern for &lt;strong&gt;pneumonia with instability&lt;/strong&gt;, &lt;strong&gt;cardiorespiratory failure&lt;/strong&gt;, or another emergency diagnosis.&lt;/li&gt;
              &lt;/ul&gt;</pre>

                <h4 style="margin:12px 0 6px">Primary care management (HTML)</h4>
                <pre id="htmlPCM">&lt;ul&gt;
                &lt;li&gt;&lt;strong&gt;Airway clearance:&lt;/strong&gt; encourage increased airway clearance during exacerbation (use the patient’s usual technique if trained); hydration may help. Consider prompt referral/advice from respiratory physio if available.&lt;/li&gt;
                &lt;li&gt;&lt;strong&gt;Bronchodilators&lt;/strong&gt; if wheeze/airflow limitation or coexistent asthma/COPD (per existing plan).&lt;/li&gt;
                &lt;li&gt;&lt;strong&gt;Self-management plan&lt;/strong&gt;: if the patient has a specialist “rescue pack”/plan, follow it (and still send sputum if possible).&lt;/li&gt;
              &lt;/ul&gt;</pre>

                <h4 style="margin:12px 0 6px">Who to refer (HTML)</h4>
                <pre id="htmlRefer">&lt;ul&gt;
                &lt;li&gt;&lt;strong&gt;SpO2 low&lt;/strong&gt; or new oxygen requirement; significant tachypnoea.&lt;/li&gt;
                &lt;li&gt;Marked comorbidity / frailty or unable to maintain oral intake.&lt;/li&gt;
                &lt;li&gt;&lt;strong&gt;New focal chest signs&lt;/strong&gt; or high suspicion of pneumonia.&lt;/li&gt;
                &lt;li&gt;Failure to improve, or &lt;strong&gt;rapidly worsening&lt;/strong&gt; symptoms despite antibiotics.&lt;/li&gt;
              &lt;/ul&gt;</pre>

                <h4 style="margin:12px 0 6px">Who not to refer (HTML)</h4>
                <pre id="htmlNotRefer">&lt;ul&gt;&lt;li&gt;(If no explicit ‘who not to refer’ applies, omit or keep minimal.)&lt;/li&gt;&lt;/ul&gt;</pre>

                <h4 style="margin:12px 0 6px">References (HTML)</h4>
                <pre id="htmlRefs">&lt;ol&gt;&lt;li&gt;(Add references here.)&lt;/li&gt;&lt;/ol&gt;</pre>
              </details>
            </div>

            <div id="draftText" class="section">
<h3>Bronchiectasis exacerbation — adults (primary care)</h3>

              <h4>Scope / definition</h4>
              <ul>
                <li>This page is for <strong>adults</strong> with <strong>known or likely bronchiectasis</strong> in primary care.</li>
                <li><strong>Acute exacerbation</strong> = <strong>sustained worsening</strong> from baseline over days, typically with worsening cough and <strong>increased sputum volume/purulence</strong> (± breathlessness, wheeze, haemoptysis, systemic upset).</li>
                <li>Separate pathway may be needed for: pregnancy, children, severe immunocompromise, cystic fibrosis, and patients under specialist shared-care protocols.</li>
              </ul>

              <h4>Immediate red flags (999 / ED now)</h4>
              <ul>
                <li><strong>Severe breathlessness</strong>, respiratory distress, hypoxia, exhaustion, cyanosis.</li>
                <li><strong>Sepsis</strong> / systemically very unwell.</li>
                <li><strong>Large-volume haemoptysis</strong> or haemoptysis with instability.</li>
                <li>Concern for <strong>pneumonia with instability</strong>, <strong>cardiorespiratory failure</strong>, or another emergency diagnosis.</li>
              </ul>

              <h4>Same-day assessment / consider hospital referral (SDEC/AMU/ED per local process)</h4>
              <ul>
                <li><strong>SpO2 low</strong> or new oxygen requirement; significant tachypnoea.</li>
                <li>Marked comorbidity / frailty or unable to maintain oral intake.</li>
                <li><strong>New focal chest signs</strong> or high suspicion of pneumonia.</li>
                <li>Failure to improve, or <strong>rapidly worsening</strong> symptoms despite antibiotics.</li>
              </ul>

              <h4>Assessment (what to check)</h4>
              <ul>
                <li><strong>Confirm this is bronchiectasis‑type deterioration:</strong> change in sputum (volume/colour/purulence), increased cough, breathlessness/wheeze, fatigue/fever.</li>
                <li><strong>Obs:</strong> RR, SpO2, HR, BP, temperature. Consider NEWS2 if used locally.</li>
                <li><strong>Exclude alternatives:</strong> pneumonia, asthma/COPD exacerbation, heart failure, PE, medication side-effects.</li>
                <li><strong>Risk features for resistant organisms / treatment failure:</strong> frequent recent antibiotics, recent admission, prior resistant organisms, previous <strong>Pseudomonas</strong> culture/colonisation, severe underlying lung disease.</li>
              </ul>

              <h4>Investigations (do early if feasible)</h4>
              <ul>
                <li><strong>Sputum sample for culture &amp; susceptibility</strong> (send before/at start of antibiotics where possible).</li>
                <li><strong>CXR</strong> if suspected pneumonia or new focal signs, significant systemic illness, or diagnostic uncertainty (local route/urgency).</li>
                <li>Consider <strong>FBC/CRP/U&amp;E</strong> if systemically unwell, recurrent exacerbations, or prolonged course (local practice).</li>
              </ul>

              <h4>Initial management (all patients)</h4>
              <ul>
                <li><strong>Airway clearance:</strong> encourage increased airway clearance during exacerbation (use the patient’s usual technique if trained); hydration may help. Consider prompt referral/advice from respiratory physio if available.</li>
                <li><strong>Bronchodilators</strong> if wheeze/airflow limitation or coexistent asthma/COPD (per existing plan).</li>
                <li><strong>Self-management plan</strong>: if the patient has a specialist “rescue pack”/plan, follow it (and still send sputum if possible).</li>
              </ul>

              <h4>Antibiotics (follow local antimicrobial guidance; use prior sputum results)</h4>
              <ul>
                <li><strong>Offer an antibiotic</strong> for an acute exacerbation.</li>
                <li><strong>Oral first line</strong> if can take oral treatment and not severely unwell.</li>
                <li>In adults without current susceptibility data (and guided by most recent sputum results), NICE NG117 lists typical <strong>first-choice oral options</strong> as: <strong>amoxicillin</strong>, <strong>doxycycline</strong>, or <strong>clarithromycin</strong> (choose per allergy/pregnancy/local policy).</li>
                <li>If higher risk of treatment failure, NICE NG117 lists <strong>co‑amoxiclav</strong> as an alternative empirical option; seek advice for fluoroquinolones (due to safety restrictions) and for suspected resistant organisms.</li>
                <li><strong>Pseudomonas / resistant organism history:</strong> do <strong>not</strong> guess — use previous microbiology and/or seek specialist/microbiology advice; ensure prompt escalation pathways are clear.</li>
                <li><strong>Course length:</strong> <strong>7–14 days</strong> depending on severity/history/response; many patients (especially more severe disease) are treated for <strong>14 days</strong> (specialist guidance/local protocol).</li>
              </ul>

              <h4>Review / reassess</h4>
              <ul>
                <li>Safety-net: seek urgent help if rapidly worse, systemically very unwell, or new red flags.</li>
                <li>Reassess if symptoms are <strong>not improving</strong> or the patient needs <strong>repeated courses</strong>:
                  <ul>
                    <li>Consider pneumonia/alternative diagnosis.</li>
                    <li>Check sputum result and <strong>only change antibiotic</strong> based on resistance/poor response (use narrow-spectrum where possible).</li>
                    <li>Seek specialist advice (consider community IV antibiotics if available).</li>
                  </ul>
                </li>
              </ul>

              <h4>When to refer / who should be under respiratory follow-up (principles)</h4>
              <ul>
                <li><strong>Hospital / same-day assessment</strong> for severe illness or suspected complications (see above).</li>
                <li><strong>Seek respiratory advice/referral</strong> if:
                  <ul>
                    <li>Symptoms not improving with repeated antibiotic courses, or</li>
                    <li>Suspected/known resistant organisms (e.g. prior <strong>Pseudomonas</strong>) and no clear current plan, or</li>
                    <li><strong>Frequent exacerbations</strong> (e.g. ≥3/year), recurrent admissions, or overall deterioration, or</li>
                    <li>Chronic colonisation with high-risk organisms (Pseudomonas, NTM, MRSA) or on long-term antibiotics (shared care).</li>
                  </ul>
                </li>
              </ul>

              <h4>Local agreement needed (D&amp;G)</h4>
              <ul>
                <li><label><input type="checkbox" /> What is the local <strong>first-line oral antibiotic</strong> guidance for bronchiectasis exacerbation (and the default course length)?</label></li>
                <li><label><input type="checkbox" /> How do practices access <strong>sputum pots</strong> and what is the <strong>courier / lab</strong> route and turnaround time?</label></li>
                <li><label><input type="checkbox" /> What is the local <strong>same-day assessment</strong> route for severe exacerbation / hypoxia / suspected pneumonia (SDEC/AMU/ED)?</label></li>
                <li><label><input type="checkbox" /> Is there access to <strong>community/home IV antibiotics</strong> for bronchiectasis (who refers, criteria)?</label></li>
                <li><label><input type="checkbox" /> Access to <strong>respiratory physiotherapy</strong> / airway clearance support during exacerbations (community vs hospital).</label></li>
              </ul>

              <div class="callout warn">
                <strong>Reminder</strong>
                <div class="small">Don’t miss pneumonia: new focal signs, fever/systemic illness, hypoxia or significant deterioration should lower the threshold for CXR and same-day assessment.
            </div>
          </div>

          <div class="panel" role="tabpanel" data-panel="refs">
            <div class="section">
              <h3>References (retrieved 2026‑02‑06)</h3>
              <ol>
                <li>RCOG Green‑top Guideline No. 34: Ovarian Cysts in Postmenopausal Women (consensus update Dec 2025; web page last reviewed 05 Dec 2025). <a href="https://www.rcog.org.uk/guidance/browse-all-guidance/green-top-guidelines/ovarian-cysts-in-postmenopausal-women-green-top-guideline-no-34/">rcog.org.uk</a></li>
                <li>NICE NG12: Suspected cancer — recommendations organised by site of cancer (ovarian cancer section; CA‑125 ≥35 → USS). <a href="https://www.nice.org.uk/guidance/ng12/chapter/Recommendations-organised-by-site-of-cancer">nice.org.uk</a></li>
                <li>Right Decisions (GGC primary care): Ovarian cysts in post-menopausal women (example of local thresholds/RMI approach; not D&amp;G). <a href="https://www.rightdecisions.scot.nhs.uk/ggc-primary-care/womens-health/gynaecology-clinical-guidelines/ovarian-cysts-in-post-menopausal-women-549/">rightdecisions.scot.nhs.uk</a></li>
              </ol>
            </div>
          </div>

        </div>
      </div>

      <div class="footer">
        <a href="../index.html">← Back to topics</a>
      </div>
    </div>
  </div>

  <script src="../assets/site.js"></script>
</body>
</html>
